Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in Japan. [PDF]
Xu Y +8 more
europepmc +1 more source
A Genome-Wide Association Study Identifying Novel Genetic Markers of Response to Treatment with Interleukin-23 Inhibitors in Psoriasis. [PDF]
Zachari S +10 more
europepmc +1 more source
Case Report: Interleukin-23 blockade achieves sustained remission in Niemann-Pick type C-associated Crohn's disease refractory to anti-tumor necrosis factor therapy. [PDF]
Kakiuchi T +4 more
europepmc +1 more source
Novel Cyclic Peptides as Interleukin-23 Inhibitor for Treating Inflammatory Disorders. [PDF]
Hu QL, Liang SH.
europepmc +1 more source
Interleukin 12/23 and interleukin 23 inhibitors for moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. [PDF]
Sawaf B +14 more
europepmc +1 more source
Favourable response of Blaschko linear psoriasis to interleukin-23 inhibition. [PDF]
Reich JLK +3 more
europepmc +1 more source
MCC950 Alleviates Experimental Autoimmune Neuritis by Inhibiting NLRP3 Inflammasome Activity and Down-Regulating Interleukin-23/Interleukin-17 Axis Expression. [PDF]
Li Y +7 more
europepmc +1 more source
The Role of Interleukin-23 and Interleukin-17 in Peri-Implant Crevicular Fluid of Subjects With Peri-Implant Disease: A Systematic Review. [PDF]
Alarcón-Sánchez MA +5 more
europepmc +1 more source
Anti-interleukin-23 treatment linked to improved <i>Clostridioides difficile</i> infection survival. [PDF]
Madden GR +3 more
europepmc +1 more source

